Background Previous studies provide considerable evidence that excitat
ion-contraction coupling may be disturbed at the level of the sarcopla
smic reticulum (SR) in the failing human heart. Disturbed SR function
may result from altered expression of calcium-handling proteins. Metho
ds and Results Levels of SR proteins involved in calcium release (ryan
odine receptor), calcium binding (calsequestrin, calreticulin), and ca
lcium uptake (calcium ATPase, phospholamban) were measured by Western
blot analysis in nonfailing human myocardium (n=7) and in end-stage fa
iling myocardium due to dilated cardiomyopathy (n=14). The levels of t
he ryanodine receptor, calsequestrin, and calreticulin were not signif
icantly different in nonfailing and failing human myocardium. Phosphol
amban protein levels (pentameric form) normalized per total protein we
re decreased by 18% in the failing myocardium (P<.05). However, phosph
olamban protein levels were not significantly different in failing and
nonfailing myocardium when normalization was performed per calsequest
rin. Protein levels of SR calcium ATPase, normalized per total protein
or per calsequestrin, were decreased by 41% (P<.001) or 33% (P<.05),
respectively, in the failing myocardium. Furthermore, SR calcium ATPas
e was decreased relative to ryanodine receptor by 37% (P<.05) and rela
tive to phospholamban by 28% (P<.05).Conclusions Levels of SR proteins
involved in calcium binding and release are unchanged in failing dila
ted cardiomyopathy. In contrast, protein levels of calcium ATPase invo
lved in SR calcium uptake are reduced in the failing myocardium. Moreo
ver, SR calcium ATPase is decreased relative to its inhibitory protein
, phospholamban. These findings support the concept that reduced capac
ity of the SR to accumulate calcium may reflect a major defect in exci
tation-contraction coupling in human heart failure.